Cargando…
Trained immunity as a potential target for therapeutic immunomodulation in Duchenne muscular dystrophy
Dysregulated inflammation involving innate immune cells, particularly of the monocyte/macrophage lineage, is a key contributor to the pathogenesis of Duchenne muscular dystrophy (DMD). Trained immunity is an evolutionarily ancient protective mechanism against infection, in which epigenetic and metab...
Autores principales: | Petrof, Basil J., Podolsky, Tom, Bhattarai, Salyan, Tan, Jiahui, Ding, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309206/ https://www.ncbi.nlm.nih.gov/pubmed/37398642 http://dx.doi.org/10.3389/fimmu.2023.1183066 |
Ejemplares similares
-
TLR4 is a regulator of trained immunity in a murine model of Duchenne muscular dystrophy
por: Bhattarai, Salyan, et al.
Publicado: (2022) -
Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2
por: Mojumdar, Kamalika, et al.
Publicado: (2014) -
CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022) -
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
por: Sun, Chengmei, et al.
Publicado: (2020) -
Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
por: Fortunato, Fernanda, et al.
Publicado: (2021)